Master One Thing - Rapamycin Longevity Series cover image

Brian Kennedy on Rapamycin Master Series | Aging is the biggest risk factor for age-related diseases

Master One Thing - Rapamycin Longevity Series

00:00

Plans for the Rapa Mysen trial and considerations for the study population

Discussion on plans to start the Rapa Mysen trial, which aims to examine a wide range of aging parameters, with a focus on inflammatory markers. The chapter also mentions the potential positive response of older individuals in similar studies.

Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner
Get the app